Experience with ospemifene in a patient with vulvovaginal atrophy and dyslipidemia: a case study
The changes that occur in sex hormone levels, body composition, and lipid/lipoprotein levels during the menopause transition, together with vascular remodeling, increase the risk of cardiovascular disease (CVD) in postmenopausal women. Any treatments prescribed for concomitant conditions during meno...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BioExcel Publishing Ltd
2020-07-01
|
| Series: | Drugs in Context |
| Subjects: | |
| Online Access: | https://www.drugsincontext.com/experience-with-ospemifene-in-a-patient-with-vulvovaginal-atrophy-and-dyslipidemia:-a-case-study/ |